Blue Jet Healthcare Limited has reported a significant adjustment in its shareholding structure, with promoter Akshay Bansarilal Arora divesting 10,734,529 equity shares, representing 6.19% of the company. The sale, conducted via an Offer for Sale (OFS) on September 10 and 11 across BSE and NSE, reduces the promoter group’s holding from 86.00% to 79.81%, while raising public shareholding from 14.00% to 20.19%.
Stake Sale Execution
The divestment was carried out through a consortium of brokers including ICICI Securities, Kotak Securities, Motilal Oswal Financial Services, and Nomura Financial Advisory and Securities (India) Pvt. Ltd. The transaction adhered to SEBI’s guidelines for minimum public shareholding, ensuring broader market participation and compliance with regulatory norms.
Strategic and Regulatory Significance
The stake sale aligns with SEBI’s minimum public shareholding (MPS) requirements, which mandate listed companies to maintain a minimum public float. By reducing the promoter stake and increasing public ownership, Blue Jet Healthcare ensures regulatory compliance while potentially enhancing the liquidity of its shares in the market.
Corporate Disclosure
The company formally communicated the transaction on September 12 under Regulation 30 of SEBI (LODR) Regulations, 2015, with Company Secretary and Compliance Officer Sweta Poddar overseeing the disclosure.
Outlook
This strategic adjustment not only fulfills regulatory obligations but may also positively influence the company’s free float, market visibility, and trading dynamics. Stakeholders and market watchers are likely to monitor the impact on liquidity and participation as a result of this change in shareholding.
Summary
- Promoter Stake Sold: 6.19% (10,734,529 shares)
- Promoter Holding After Sale: 79.81%
- Public Holding After Sale: 20.19%
- Purpose: Compliance with SEBI minimum public shareholding norms
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.